Position in XGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$134
-$59,338 QoQ
Shares Held
29
-99.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 57 holders
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $1,577,629,116 across 35 Diagnostics & Research names. XGN ranks #34 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
737,831 | $369,918,950 | |
| 2 | DHR |
Danaher Corp /De/
|
1,384,954 | $263,806,037 | |
| 3 | A |
Agilent Technologies, Inc.
|
1,451,332 | $192,780,429 | |
| 4 | WAT |
Waters Corp /De/
|
235,147 | $88,189,530 | |
| 5 | DGX |
Quest Diagnostics Inc
|
395,245 | $83,772,177 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
62,447 | $79,776,666 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
141,180 | $74,322,799 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
367,195 | $70,949,417 |
All Filings in XGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $134 | 29 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $59,472 | 19,824 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $810,111 | 133,242 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $514,683 | 46,832 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $237 | 34 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $104 | 29 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $118 | 29 | Shares | Defined | 2025-02-14 | |
| 2022-09-30 | $457 | 169 | Shares | Defined | 2022-11-16 | |
| No filing history on record for this holder in this stock. | ||||||